These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3937441)

  • 1. A Belgian multicentre study of fluvoxamine in depressive outpatients.
    Brasseur R; Van Moffaert M; Mesotten F; Ansseau M; Uytdenhoef P; Bartholome F
    Acta Psychiatr Belg; 1985; 85(5):636-43. PubMed ID: 3937441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flupenthixol and fluvoxamine in mild to moderate depression: a comparison in general practice.
    Hamilton BA; Jones PG; Hoda AN; Keane PM; Majid I; Zaidi SI
    Pharmatherapeutica; 1989; 5(5):292-7. PubMed ID: 2501801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.
    Nathan RS; Perel JM; Pollock BG; Kupfer DJ
    J Clin Psychiatry; 1990 Sep; 51(9):367-72. PubMed ID: 2120201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvoxamine in the treatment of tricyclic-resistant depression.
    White K; Wykoff W; Tynes LL; Schneider L; Zemansky M
    Psychiatr J Univ Ott; 1990 Sep; 15(3):156-8. PubMed ID: 2123039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affective disorders in general practice. Treatment of 6000 patients with fluvoxamine.
    Martin AJ; Tebbs VM; Ashford JJ
    Pharmatherapeutica; 1987; 5(1):40-9. PubMed ID: 3110794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre open trial of fluoxetine in depressed out-patients in Belgium.
    Brasseur R
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():107-11. PubMed ID: 2644335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives.
    Emrich HM; Berger M; Riemann D; von Zerssen D
    Pharmacopsychiatry; 1987 Mar; 20(2):60-3. PubMed ID: 3108909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression.
    de Jonghe F; Swinkels J; Tuynman-Qua H
    Pharmacopsychiatry; 1991 Jan; 24(1):21-7. PubMed ID: 1901418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E; Feighner J; Mandos LA; Rickels K
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
    Mendels J; Reimherr F; Marcus RN; Roberts DL; Francis RJ; Anton SF
    J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind controlled clinical trial comparing fluvoxamine with imipramine.
    Guelfi JD; Dreyfus JF; Pichot P
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):411S-417S. PubMed ID: 6407501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial clinical evaluation of a new nontricyclic antidepressant: clovoxamine.
    Freeman HL; Wakelin JS; Calanca A; Hole G
    Adv Biochem Psychopharmacol; 1982; 32():69-75. PubMed ID: 7046368
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
    Guy W; Wilson WH; Ban TA; King DL; Manov G; Fjetland OK
    Psychopharmacol Bull; 1984; 20(1):73-8. PubMed ID: 6425916
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study.
    Gonella G; Baignoli G; Ecari U
    Curr Med Res Opin; 1990; 12(3):177-84. PubMed ID: 2125547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term study of fluvoxamine: a new rapid-acting antidepressant.
    Feldmann HS; Denber HC
    Int Pharmacopsychiatry; 1982; 17(2):114-22. PubMed ID: 6809683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression.
    Roth D; Mattes J; Sheehan KH; Sheehan DV
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):929-39. PubMed ID: 2126144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent studies on selective serotonergic antidepressants: trazodone, fluoxetine, and fluvoxamine.
    Schatzberg AF; Dessain E; O'Neil P; Katz DL; Cole JO
    J Clin Psychopharmacol; 1987 Dec; 7(6 Suppl):44S-49S. PubMed ID: 3123528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
    Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.